Celestica: A Lower-Cost Route Into the AI Infrastructure Build-Out

Hook & thesis

Celestica is an under-appreciated ways-to-play the AI infrastructure build-out. The company manufactures and integrates servers, storage and networking boxes for hyperscalers and telecom customers while also maintaining a diversified Advanced Technology Solutions business. Recent headlines and analyst upgrades have highlighted outsized revenue and EPS revisions tied to demand for 800G/1.6T switches and AI compute solutions, and technical momentum is showing through.

My trade idea: take a tactical long on CLS at current levels to ride continued hyperscaler capex and supply-chain re-shoring. The setup pairs measurable upside catalysts with a clear downside stop—this is a risk-managed trade, not a buy-and-forget speculation.

Business summary - why the market should care

Celestica operates two core segments: Connectivity and Cloud Solutions (CCS) and Advanced Technology Solutions (ATS). CCS supplies enterprise communications, telecom, servers and storage hardware to hyperscalers and network operators. ATS covers aerospace & defense, industrial, health tech and capital equipment, providing diversification and higher-margin aftermarket work.

Why investors should care: hyperscalers are in the middle of an AI infrastructure refresh that favors high-performance networking (800G, 1.6T) and bespoke server/storage builds. Celestica is a direct supplier into that stack; one recent analyst write-up attributes a large portion of Celestica's 2026 upside to demand for next-gen Ethernet switches and AI compute boxes and even cites partnerships and design wins that position the company to capture outsourced manufacturing work.

Concrete data backing the case

• Share price and market size: CLS trades at $356.05 with a market capitalization of roughly $44.94 billion.
• Valuation metrics: trailing P/E ~35.77 and P/B ~15.97. Those metrics show the market is pricing growth expectations into the stock today rather than treating it as a low-margin commodity EMS play.
• Technical momentum: 9-day EMA is ~$334.08 versus current price $356.05, and the 10-day SMA sits at $332.52; RSI is ~60.3 and MACD is bullish with a positive histogram—momentum supports a trend-following entry.
• Liquidity and investor behavior: two-week average daily volume is ~2.1M shares, and recent short-interest snapshots show active shorting (short interest around ~3.99M on 08/31) but days-to-cover is modest (~2 days), which caps the risk of a dramatic short squeeze while still reflecting interest from contrarian shorts.
• Market context: multiple recent analyst pieces and Zacks coverage boosted estimates—some write-ups project very strong 2026 sales and EPS growth driven by AI and networking demand.

Valuation framing

At a market cap of ~$44.94B and a trailing P/E near 36, Celestica is not cheap in absolute terms. That said, valuation has to be viewed against the expected revenue/EPS acceleration tied to AI-related products and services. Recent analyst commentary points to very steep 2026 growth expectations (multiple write-ups reference >60% sales growth and double-digit EPS expansion in 2026). In that context, the current P/E looks more like a growth multiple than an EMS multiple.

Compare qualitatively to legacy EMS peers: many contract manufacturers trade on single-digit to mid-teens multiples when their revenue mix skews to consumer electronics. Celestica's higher multiple reflects the mix shift toward high-value networking, server and cloud hardware. For a trader, this means rewards are tied tightly to cadence of hyperscaler orders and reported bookings—monitor those closely.

Catalysts (what can drive the stock higher)

• Quarterly results showing continued sequential revenue growth in CCS and improved gross margins from AI-related products.
• Confirmed design wins or expanded supply agreements with hyperscalers or cloud OEMs (public disclosures or press releases).
• Upgrades or positive estimate revisions from sell-side analysts—recent consensus move higher demonstrates the sensitivity of the stock to estimate momentum.
• Macro tailwinds: continued hyperscaler capex on AI racks and broader telecom spending on 5G/Open RAN that requires high-speed optics and switching.
• Operational improvements in ATS (HealthTech wins) that add higher-margin recurring revenue and reduce cyclicality.

Trade plan - actionable entry, stop, target and horizon

Recommended action: enter a long position at $356.05 (current price). This is a tactical trade with a defined stop and asymmetric upside target.

Time horizons and how to manage them:

• Short term (10 trading days) - Use this window to confirm technical follow-through. If price holds above the 9-day EMA (~$334) and daily MACD momentum persists, keep the position. Failure to hold the 9-day EMA would be a red flag.
• Mid term (45 trading days) - Expect news flow (analyst notes, design-win headlines) that can move the stock; a confirmed quarter-beat or a large publicized OEM deal in this window should allow trimming and partial profits toward the $420 target.
• Long term (180 trading days) - If hyperscaler capex sustains and Celestica reports multiple quarters of outsized CCS growth and margin improvements, re-evaluate valuation versus forward EPS; consider holding into multi-quarter appreciation or rotating some gains into pure-play AI infra names.

Risks & counterarguments

Every trade has risk. Below are the principal downside scenarios and a counterargument to the bull case.

• Customer concentration and order volatility - Hyperscaler orders tend to be lumpy. A pause or re-phasing from a single large customer could sharply pressure revenue and margins.
• Supply chain and execution risk - While Celestica benefits from outsourced manufacturing demand, execution failures (component shortages, factory disruptions) could hit margins and delivery schedules.
• Valuation sensitivity - The market currently prices meaningful growth into CLS (P/E ~35.8). Disappointing quarters will likely produce outsized downside as growth expectations reset.
• Competition and integration risk - Larger EMS peers or in-house builds by hyperscalers could capture wallet share; new entrants or price competition could compress prices/margins.
• Macro capex swings - AI infrastructure spending is cyclical and tied to macro and corporate budgeting cycles. A broad capex pause would hurt order flow.

Counterargument: Some investors will argue that Celestica is still an EMS play and therefore should trade at lower multiples; that’s valid if the company fails to prove recurring, high-margin AI-related revenue. The bull case requires multiple quarters of revenue mix shift and margin improvement to justify current multiples. If Celestica cannot convert design wins into repeatable volume, the upside will be limited.

What will change my mind

I will materially increase the conviction on CLS (add size) if the company posts two consecutive quarters of outsized CCS revenue growth accompanied by expanding gross margins and provides transparent disclosure on hyperscaler design-win conversions. Conversely, a miss in bookings or an announcement of large order cancellations would prompt exiting the trade and reassessing the thesis.

Conclusion

Celestica offers a practical, lower-cost way to play AI infrastructure beyond the headline names. The stock already reflects some growth expectations, so this trade is about execution: headline design-wins converting to volume and margin expansion. The technical indicators and analyst momentum support a measured long entry at $356.05 with a $320 stop and $420 target. Keep the position sizing modest and watch quarterly order flow and margin commentary closely—those will determine whether this trade moves from tactical to conviction.

Key monitoring points: quarterly CCS revenue trends, gross margin trajectory, publicized OEM/hyperscaler wins, and any meaningful changes in short interest or days-to-cover.